EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 13

Ensembl ID : ENSUAMG00000009145
Gene Symbol: MAP3K13
2 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 5

Ensembl ID : ENSUAMG00000006263
Gene Symbol: MAP3K5
2 Cross references
203 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 9

Ensembl ID : ENSUAMG00000026095
Gene Symbol: MAP3K9
2 Cross references
194 Possible Orthologues:

Monoamine Oxidase B

Ensembl ID : ENSUAMG00000027637
Gene Symbol: MAOB
2 Cross references
330 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSUAMG00000021533
Gene Symbol: MGLL
2 Cross references
208 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSUAMG00000005931
Gene Symbol: MLNR
2 Cross references
165 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSUAMG00000019830
Gene Symbol: NPR1
2 Cross references
184 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSUAMG00000008567
Gene Symbol: NPR2
2 Cross references
259 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSUAMG00000000187
Gene Symbol: NPR3
2 Cross references
211 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSUAMG00000017044
Gene Symbol: NPY5R
2 Cross references
135 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSUAMG00000012858
Gene Symbol: NTSR1
2 Cross references
211 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSUAMG00000013675
Gene Symbol: NTRK1
2 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).